Download Chapter 23

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Discovery and development of ACE inhibitors wikipedia , lookup

Psychopharmacology wikipedia , lookup

Discovery and development of beta-blockers wikipedia , lookup

Neuropharmacology wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Discovery and development of angiotensin receptor blockers wikipedia , lookup

Transcript
Chapter 23
Drugs Used to Treat Hypertension
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 23
Lesson 23.1
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
2





Discuss blood pressure and its
measurement
Define hypertension
Differentiate between primary and
secondary hypertension
Summarize nursing assessments and
interventions used for the treatment of
hypertension
State recommended lifestyle modifications
for a diagnosis of hypertension
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
3
 Characterized by an elevation of systolic blood
pressure (sbp), diastolic blood pressure (dbp) or
both
◦ Primary hypertension: 90% of cases, unknown cause
◦ Secondary hypertension: occurs after another
disorder
 Normal BP: less than 120 sbp, less than 80 dbp
 Prehypertension: 120 to 139 sbp, or 80 to 89
dbp
 Stage I: 140 to 159 sbp or 90 to 99 dbp
 Stage 2: greater than or equal to160 sbp or
greater than or equal to 100 dbp
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
4
 Smoking
 Obesity
 Physical inactivity
 Dyslipidemia
 Diabetes mellitus
 Microalbuminuria or estimated glomerular
filtration rate (GRF) less than 60 mL/min
 Age (older than 55 for men, older than 65
for women)
 Family history of premature cardiovascular
disease
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
5
 Target organ damage
◦
◦
◦
◦
◦
Heart
Brain
Kidneys
Blood vessels
Eyes
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Slide 6
 Blood pressure sitting for 5 minutes
quietly; no recent caffeine products
 Family history and risk factors present
 Laboratory data for lipids, triglycerides,
cholesterol, renal function studies
 BMI
 Peripheral pulses
 Patient education focuses on lifestyle
modifications
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
7
 Lifestyle modifications
Smoking cessation
Weight reduction
DASH diet
Physical activity
Restriction in alcohol intake
Stress reduction
Regular sleep pattern of at least 7 hours each
night
◦ Sodium control
◦
◦
◦
◦
◦
◦
◦
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
8
Chapter 23
Lesson 23.2
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
9





Identify specific factors the hypertensive
patient can use to assist in managing the
disease
Identify 10 classes of drugs used to treat
hypertension
Review Figure 23-2 to identify options and
progression of treatment for hypertension
Develop patient education objectives for
individuals with hypertension
Summarize the action of each drug class
used to treat hypertension
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
10
 Long-term success depends on patients
understanding the characteristics and
diseases that contribute to the issue
◦ Demographic characteristics – age, gender, race
◦ Coexisting diseases and risk factors – migraine
headaches, dysrhythmias, angina, diabetes
mellitus, previous therapy used, concurrent
therapy, cost of treatment
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
11





Lifestyle modifications are initial therapy
If no significant effect, drug therapy is
introduced
Start with diuretics for stage 1 hypertension
Add beta blockers(lol), ACE inhibitors(pril),
calcium channel blockers(dipine), and
angiotensin receptor blockers(ARBs) as
tolerated
Start with two-drug combination for stage 2
hypertension
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
12





Diuretics; beta-adrenergic blocking (lol)
agents
ACE inhibitors (pril); angiotensin II receptor
blockers (ARBs)
Direct renin inhibitors; aldosterone
receptor antagonist
Calcium channel blockers (dipine); alpha-1
adrenergic blocking agents
Central-acting alpha-2 agonists;
peripheral-acting adrenergic antagonists;
direct vasodilators
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
13
 Actions
◦ Cause volume depletion, sodium excretion,
vasodilation of peripheral arterioles
 Uses
◦ Most commonly prescribed antihypertensives
◦ In combination with other antihypertensive
agents
◦ Discussed further in Chapter 29
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
14
 Actions
◦ Inhibit cardiac response to sympathetic nerve
stimulation
◦ Inhibit renin release from kidneys
 Uses
◦ Initial therapy for stage 1 and 2 hypertension
 Common adverse effects
◦ Bradycardia, peripheral vasoconstriction (purple
mottled skin); heart failure; bronchospasm,
wheezing; masks hypoglycemia in diabetic
patients
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
15
 Actions
◦ Inhibit angiotensin I converting enzyme (ACE),
disrupting the conversion of angiotensin I to
angiotensin II
 Uses
◦ Single therapy for stage 1 or 2 hypertension
 Common adverse effects
◦ Nausea, fatigue, headache, diarrhea; orthostatic
hypotension
 Serious adverse effects
◦ Angioedema; neutropenia; hyperkalemia;
chronic cough; birth defects
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
16
 Actions
◦ Bind to angiotensin II receptor sites and block
the vasoconstrictor from binding to receptor
sites in target organs
 Uses
◦ Alone or in combination with other
antihypertensives to reduce blood pressure
 Common adverse effects
◦ Dyspepsia, cramps, diarrhea; headache;
orthostatic hypotension
 Serious adverse effects
◦ Birth defects; hyperkalemia
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
17
 Drug: aliskiren (Tekturna)
 Actions
◦ Block the first step in the RAAS cascade
preventing release of aldosterone
 Uses
◦ Alone or in combination with other
antihypertensives to reduce blood pressure
 Common adverse effects
◦ Dyspepsia, cramps, diarrhea; headache;
orthostatic hypotension
 Serious adverse effects
◦ Altered fluid and electrolytes, birth defects
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
18
 Drug: eplerenone (Inspra)
 Actions
◦ Block stimulation of aldosterone at receptor
sites, preventing sodium reabsorption
 Uses
◦ Alone or in combination with other
antihypertensives to reduce blood pressure
 Common adverse effects
◦ Nausea, diarrhea; fatigue, headache; orthostatic
hypotension
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
19
 Actions
◦ Inhibit movement of calcium ions across cell
membranes
 Uses
◦ Ideal for first- or second-line drug therapy for
hypertension
 Serious adverse effects
◦ Hypotension and syncope
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
20
 Actions
◦ Block postsynaptic alpha-1 adrenergic receptors
to produce vasodilation, decrease peripheral
vascular resistance
 Uses
◦ Alone or in combination with other
antihypertensives to reduce blood pressure
◦ Reduce mild to moderate urinary obstruction
 Common adverse effects
◦ Drowsiness, headache, weakness, lethargy;
dizziness, tachycardia, fainting
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
21
 Actions
◦ Stimulate alpha-adrenergic receptors in the
brainstem, reducing sympathetic outflow from
CNS
 Uses
◦ Considered adjunctive therapy; used only in
combination with other antihypertensives
 Common adverse effects
◦ Drowsiness, dry mouth, dizziness, altered urine
color, altered rest results
 Serious adverse effects
◦ Depression; rash
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
22
 Actions
◦ Relax arterial smooth muscle, reducing
peripheral vascular resistance
 Uses
◦ Treatment of stage 2 hypertension, renal
disease hypertension, toxemia of pregnancy
 Common adverse effects
◦ Dizziness, numbness, tingling in legs;
orthostatic hypotension, palpitations,
tachycardia; nasal congestion; hair growth
 Serious adverse effects
◦ Fever, chills, joint and muscle pain, skin
eruptions; gynecomastia
Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Sli
de
23